Gene description for ERBB2 |
Gene name |
erb-b2 receptor tyrosine kinase 2 |
Gene symbol |
ERBB2 |
Other names/aliases |
CD340 HER-2 HER-2/neu HER2 MLN 19 MLN-19 NEU NGL TKR1 VSCN2 c-ERB-2 c-ERB2 p185(erbB2) |
Species |
Homo sapiens |
Experiment description of studies that identified ERBB2 in Serum |
1
|
Experiment ID | 217 |
Identified molecule | protein
|
Extracellular vesicle type | Exosomes |
MISEV | EVs |
Identification method | ELISA Dot blot
|
PubMed ID |
21293856
|
Organism | Homo sapiens |
Experiment description | Tumour exosomes inhibit binding of tumour-reactive antibodies to tumour cells and reduce ADCC |
Authors | Battke C, Ruiss R, Welsch U, Wimberger P, Lang S, Jochum S, Zeidler R |
Journal name |
Cancer Immunol Immunother
|
Publication year | 2011 |
Sample | Serum |
Sample name | Serum - Breast cancer |
Isolation/purification methods | Differential centrifugation Filtration Ultrafiltration Ultracentrifugation Sucrose density gradient |
Flotation density | 1.13-1.17 g/mL |
Molecules identified in the study | Protein |
Methods used in the study | ELISA Dot blot |
EV-TRACK |
EV110080: EV-METRIC:14%, 14%, 38%
|
|
|
2
|
Experiment ID | 971 |
Identified molecule | protein
|
Extracellular vesicle type | Exosomes |
MISEV | EVs |
Identification method | Mass spectrometry
|
PubMed ID |
22808001
|
Organism | Homo sapiens |
Experiment description | Biochemical and physical characterisation of urinary nanovesicles following CHAPS treatment. |
Authors | Musante L, Saraswat M, Duriez E, Byrne B, Ravidà , Domon B, Holthofer H. |
Journal name |
PLoS One
|
Publication year | 2012 |
Sample | Serum |
Sample name | Serum -Tuberculosis patient 1 |
Isolation/purification methods | Filtration ExoQuick |
Flotation density | - |
Molecules identified in the study | Protein |
Methods used in the study | Mass spectrometry |
EV-TRACK |
EV120006: EV-METRIC:56%
|
|
|